| For: | Arnedo RD, Polo VS, Garcia JB, Gutiérrez JF, Clason ER, Domínguez D, Rebutti GM, Mancia CM, López RT, Meza MR, López DT, Muñoz Zambrano JJ, Herrera EL, Dina-Batlle E, Terrones MC, de Moraes TP, Yánez TR, Osorio W, Cabeza AA, Rico-Fontalvo J. Efficacy and safety of finerenone in diabetic kidney disease: Latin American experience from FINDKDLATAM trial. World J Nephrol 2026; 15(1): 115933 [PMID: 41884241 DOI: 10.5527/wjn.v15.i1.115933] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v15/i1/115933.htm |
| Number | Citing Articles |
| 1 |
Jorge Rico Fontalvo, Alyi A. Arrellano-Cabeza , Javier Jiménez-Quintero , Tomás Rodríguez-Yánez, Luisa Rodríguez-Rosero , Felipe Candela-Bustamante, Rodrigo Daza-Arnedo . Evidencia actual del uso de finerenona en el continuo cardio-reno-metabólico. Revisión narrativa. Revista de la Sociedad Paraguaya de Nefrología 2026; 4(1) doi: 10.70108/nefrologiapy.2026.4.1.44
|
| 2 |
Jorge Rico Fontalvo, María Raad Sarabia, José C. De La Flor, Vicente Sánchez Polo, Jenniffer Benavides Garcia, Enrique Ramos Clason, Daniel Domínguez, Giovanny Mera Rebutti, Carlos Madrid Mancia, Rene Tabora López, Manuel Rocha Meza, Dany Tabora López, James J. Muñoz Zambrano, Eduardo Lorca Herrera, Eliana Dina-Batlle, Michael Cieza Terrones, Thyago Proença de Moraes, Tomas Rodríguez Yánez, Washington Osorio, Alyi Arellano Cabeza, Rodrigo Daza Arnedo. Efficacy and Safety of Finerenone in Patients Aged 65 Years or Older with Diabetic Kidney Disease: Subgroup Analysis of the FINDKDLATAM Study. Medicina 2026; 62(7) doi: 10.3390/medicina62071317
|